Biomarin Pharmaceutical Inc.

BMRN·NASDAQ·$52.88Share Price as of 11/2·$10BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2510/28/25 10-QQ2 ended 06/30/2508/05/25

Disclosures

8-KCurrent report10/06/26 8-KCurrent report09/30/26 8-KCurrent report09/15/26 8-KCurrent report09/14/26 8-KCurrent report09/01/26

Prospectuses and Registrations

S-8Registration of securities for employees08/06/26 S-8Registration of securities for employees08/05/25 S-8Registration of securities for employees11/02/23 S-8Registration of securities for employees02/17/22 S-8Registration of securities for employees10/16/19

Proxies

DEF 14ADefinitive proxy04/21/26 DEFA14AAdditional proxy materials04/21/26 DEF 14ADefinitive proxy04/08/25 DEFA14AAdditional proxy materials04/08/25 DEF 14ADefinitive proxy04/09/24

Ownership

Form 4Insider transaction10/01/26 Form 3Initial insider ownership09/14/26 Form 4Insider transaction09/14/26 Form 4Insider transaction09/03/26 144Proposed sale of securities09/02/26

Other

ARSAnnual report to shareholders04/21/26 SC TO-T/ASC TO-T/A07/01/25 SC TO-T/ASC TO-T/A06/17/25 CORRESPCorrespondence with the SEC06/13/25 SC TO-T/ASC TO-T/A06/13/25